Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC) Treatment: Quo Vadis?

Antonios N Gargalionis Kostas A Papavassiliou Donatella Delle Cave

Published in: International journal of molecular sciences (2024)

Lung cancer has been established as the second most common cancer worldwide (most common cancer in men and second most common cancer in women) and as the leading cause of cancer morbidity among neoplasms [...].

Keyphrases

papillary thyroid
squamous cell
small cell lung cancer
lymph node metastasis
squamous cell carcinoma
type diabetes
childhood cancer
metabolic syndrome
young adults
middle aged